2Selman M, Thannickal VJ, Pardo A, et al. Idiopathic pulmonary fibrosis: pathogenesis and therapeutic approaches [ J ]. Dross, 2004,64 ( 4 ) : 405 - 430
3King TE Jr, SchWarz ML, Brown K, et al. Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality[J] .Am J Respir Crit Care Med, 2001,164(6) : 1025 - 1032
4Cool CD, Groshong SD, Rai PR, et al. Fibroblast foci are not discrete sites of lung injury or repair: the fibroblast reticuhm[ J] .Am J Respir Crit Care Med, 2006,174(6):654-658
5Phan SH. The myofibroblast in pulmonary fibrosis[J]. Chest,2002, 122 (6suppl) :286S - 289S
6Zhang K, Rekhter MD, Gordon D, et al.Myofibroblasts and their role in lung collagen gone expression during pulmonary fibrosis. A combined immunohistochemical and in situ hybridization study[J] .Am J Pathol, 1994,145(1) : 114 - 125
7Willis BC, Liebler JM, Luby-Phelps K, et al. Induction of epithelialmesenchymal transition in alveolar epithelial cells by transforming growth factor- beta1: potential role in idiopathic pulmonary fibrosis[J] .Am J Pat hol,2005, 166(5) : 1321 - 1332
8Abe R, Donnelly SC,Peng T, et al. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites[J]. J Immunol,2001,166 (12) :7556 - 7562.
9Wynn TA. Cellular and molecular mechanisms of fibrosis [ J ]. Pathol, 2008,214(2) : 199- 210.
10Pilewski JM, Liu L, Henry AC, et al. Inulin - like growth factor binding proteins 3 and 5 are overexpressed in idiopathic pulmonary fibrosis and contribute to extracellular matrix deposition[ J]. Am J Pathol,2005, 166(2) :399 - 407
6Young A, Koduri G, Batley M, et al. Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis[ J ]. Rheumatology, 2007,46( 2 ): 350-357.
7Young A,Koduri G, Batley M,et al. Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis [J]. Rheumatology, 2007,46(2) : 183-218.
8G Schuller-Levis,R E. Gordon,Chuanhua Wang,et al. Protection of bleomycin-induced fibrosis and inflammation by taurine[J]. International Immunopharmacology,2009,9 (7-8) : 971-977.
9Harold R. Collard,James E. Loyd,Talmadge E. King Jr,et al. Current diagnosis and management of idiopathic pulmonary fibrosis: A survey of academic physicians [J]. Respiratory Medicine, 2007,101 (9) : 2011-2016.
